Compounds > arginine

arginine and Prostatic Neoplasms

arginine has been researched along with Prostatic Neoplasms in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19902 (4.26)18.7374
1990's3 (6.38)18.2507
2000's16 (34.04)29.6817
2010's16 (34.04)24.3611
2020's10 (21.28)2.80

Authors

AuthorsStudies
Bicho, M; Carvalho, M; Matos, A; Ribeiro, R1
Hong, X; Hu, Q; Jia, R; Mao, L; Xu, L1
Juárez-López, D; Schcolnik-Cabrera, A1
Bravou, V; Grypari, IM; Megalooikonomou, V; Melachrinou, M; Papastergiou, T; Pappa, I; Tzelepi, V; Zolota, V1
Feng, N; Feng, Y; Gu, C; Hu, L; Liu, F; Lu, YJ; Sheng, J; Wang, K; Wang, Y; Xu, B; Xu, X; Yang, D; Zhang, Y; Zhu, S1
Asha Parveen, SM; Kami Reddy, KR; Ummanni, R1
Basar, H; Baydilli, N; Kaymaz, O; Murat, K; Selvi, I1
Hacioglu, C; Kacar, S; Kanbak, G; Kar, F; Sahinturk, V1
Chen, H; Chen, J; Chen, X; Gu, Y; Huang, S; Wang, H; Wu, X; Xu, Y; Zhang, H; Zhang, Y1
Gao, X; He, YH; Hu, GS; Huang, HH; Huang, MF; Li, WJ; Lin, YA; Liu, W; Peng, BL; Ran, T; Xie, BL; Yang, JJ; Ye, F; Zhu, HH1
Ann, DK; Chen, CL; Chu, CY; Chung, TY; Hsiao, PW; Hsu, SC; Kung, HJ; Wang, HJ; Yeh, SD; Yen, Y1
Ito, K; Koike, H; Matsui, H; Miyazawa, Y; Nomura, M; Sekine, Y; Shibata, Y; Suzuki, K; Syuto, T1
Dasari, C; Duscharla, D; Kumar, JM; Ram, NS; Reddy, KRK; Supriya, B; Surekha, MV; Ummanni, R1
Behjati, M; Karimian, M; Mobasseri, N; Nikzad, H; Noureddini, M1
Dasari, C; Jadav, SS; Kami Reddy, KR; Kumar, JM; Natani, S; Sai Ram, N; Supriya, B; Ummanni, R; Vandavasi, S1
Ding, J; Fu, K; Gan, W; Han, R; Han, X; Jiang, K; Li, D; Wu, J; Zhang, L1
Ann, DK; Bold, RJ; Changou, CA; Chen, YR; Cheng, RH; Chuang, FY; Kung, HJ; Xing, L; Yen, Y1
Szlosarek, PW1
Cimen Bozkus, C; Crist, SA; Ellies, LG; Elzey, BD; Ratliff, TL1
Kotamraju, VR; Ruoslahti, E; Sugahara, KN; Teesalu, T1
Ahaghotu, C; Apprey, V; Bonney, G; Dunston, GM; Josey, D; Mason, T; McLauchlin, A; Ricks-Santi, L1
Belmonte, C; Morenilla-Palao, C; Valero, M; Viana, F1
Bellone, M; Capuano, G; Freschi, M; Generoso, L; Grioni, M; Jachetti, E; Ricupito, A; Rigamonti, N1
Chen, M; Chen, SQ; Hua, LX; Tong, N; Wang, ZJ; Xu, B; Zhang, ZD1
Pi, M; Quarles, LD1
Morehouse, TJ; Thomas, LN; Too, CK1
Cheng, PN; Hsueh, CT; Hsueh, EC; Knebel, SM; Leung, YC; Lo, WH1
Carpten, JD; Casey, G; Catalona, WJ; Klein, EA; Krumroy, LM; Neville, PJ; Nupponen, N; Plummer, SJ; Silverman, RH; Trent, JM; Witte, JS; Xiang, Y1
Hescheler, J; Sauer, H; Schallenberg, M; Wartenberg, M1
Bellarosa, C; Dekleva, V; Diana, F; Giancotti, V; Manfioletti, G; Rustighi, A; Sgarra, R; Toller, M1
Ittmann, M; Stockton, DW; Wang, J1
Klibanov, AL; Lu, E; Modzelewski, RA; Villanueva, FS; Wagner, WR; Weller, GE; Wong, MK1
Battistini, L; Borsellino, G; Bronte, V; Gallana, K; Gri, G; Iafrate, M; Kasic, T; Marigo, I; Pagano, F; Prayer-Galetti, T; Viola, A1
Abrahamsson, PA; Ahlgren, G; Gadaleanu, V; Giwercman, A; Giwercman, YL1
Finley, RL; Li, X; Meng, Y; Reddy, N; Sakr, W; Sheng, S; Yang, H; Yin, S1
Kuo, MH; Lee, DY; Northrop, JP; Stallcup, MR1
Bakalarski, CE; Beausoleil, SA; Elias, JE; Everley, PA; Faherty, BK; Gerber, SA; Gygi, SP; Waghorne, CG; Zetter, BR1
Casey, G; Jorgenson, E; Liu, X; Plummer, SJ; Schumacher, FR; Witte, JS1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Cederbaum, SD; Grody, WW; Mumenthaler, SM; Pegg, AE; Seligson, DB; Tze, S; Yu, H1
Coughlin, CT; Page, RL; Richmond, RC1
Augustus, M; Bova, GS; Carter, KC; Gelmann, EP; Madike, V; Voeller, HJ1
Kumar, A; Mikolajczyk, SD; Millar, LS; Saedi, MS1
Choi, SH; Chun, BG; Chun, YS; Kang, H; Kang, SW; Min, BH; Park, IS; Shin, KH1
Blagosklonny, MV; Fojo, T; Giannakakou, P; Romanova, LY; Ryan, KM; Vousden, KH1
Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP1
Dorval, T; Garcia-Giralt, E; Jouve, M; Palangie, T; Pouillart, P1

Reviews

4 review(s) available for arginine and Prostatic Neoplasms

ArticleYear
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression.
    Nutrients, 2021, Dec-16, Volume: 13, Issue:12

    Topics: Arginase; Arginine; Disease Progression; Humans; Male; Prostate; Prostatic Neoplasms; Signal Transduction; Tumor Microenvironment

2021
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.
    Cellular oncology (Dordrecht), 2022, Volume: 45, Issue:5

    Topics: Amino Acids; Arginine; Carbohydrates; Glutamine; Humans; Leucine; Lipids; Male; Proline; Prostatic Neoplasms; Sarcosine; Serine; TOR Serine-Threonine Kinases

2022
FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
    BMC cancer, 2011, Feb-24, Volume: 11

    Topics: Amino Acid Substitution; Arginine; Biomarkers, Tumor; Carcinoma; Case-Control Studies; Cell Transformation, Neoplastic; Disease Progression; Glycine; Humans; Male; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Receptor, Fibroblast Growth Factor, Type 4

2011
Platinum drug delivery and radiation for locally advanced prostate cancer.
    International journal of radiation oncology, biology, physics, 1994, Mar-01, Volume: 28, Issue:4

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Cisplatin; Combined Modality Therapy; Humans; Male; Nitric Oxide Synthase; Prostate; Prostatic Neoplasms; Radiotherapy Dosage

1994

Trials

1 trial(s) available for arginine and Prostatic Neoplasms

ArticleYear
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
    European urology, 1975, Volume: 1, Issue:1

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms

1975

Other Studies

42 other study(ies) available for arginine and Prostatic Neoplasms

ArticleYear
Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes.
    Bioengineered, 2022, Volume: 13, Issue:1

    Topics: Animals; Antigens, Surface; Arginine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutamate Carboxypeptidase II; Humans; Male; Metabolomics; Mice; Neoplasm Transplantation; Proline; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Receptors, Androgen

2022
Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort dataset.
    Histology and histopathology, 2023, Volume: 38, Issue:3

    Topics: Access to Information; Arginine; Cell Nucleus; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Nuclear Proteins; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases

2023
Hsa_circ_0094606 promotes malignant progression of prostate cancer by inducing M2 polarization of macrophages through PRMT1-mediated arginine methylation of ILF3.
    Carcinogenesis, 2023, 05-15, Volume: 44, Issue:1

    Topics: Arginine; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Macrophages; Male; Methylation; Methyltransferases; MicroRNAs; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA; RNA, Circular

2023
Dimethylarginine Dimethylaminohydrolase - 1 expression is increased under tBHP-induced oxidative stress regulates nitric oxide production in PCa cells attenuates mitochondrial ROS-mediated apoptosis.
    Nitric oxide : biology and chemistry, 2023, 09-01, Volume: 138-139

    Topics: Amidohydrolases; Antioxidants; Apoptosis; Arginine; Humans; Male; Nitric Oxide; Oxidative Stress; Prostatic Neoplasms; Proteomics; Reactive Oxygen Species; Signal Transduction; tert-Butylhydroperoxide; Tumor Cells, Cultured

2023
The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer.
    International urology and nephrology, 2019, Volume: 51, Issue:11

    Topics: Aged; Arginine; Biomarkers, Tumor; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Prostatic Neoplasms

2019
The effects of L-NAME on DU145 human prostate cancer cell line: A cytotoxicity-based study.
    Human & experimental toxicology, 2020, Volume: 39, Issue:2

    Topics: Antineoplastic Agents; Arginine; Cell Enlargement; Cell Proliferation; Cell Survival; Cytotoxins; Enzyme Inhibitors; Humans; Male; Nitric Oxide Synthase; Prostatic Neoplasms; Tumor Cells, Cultured

2020
Study on the cellular internalization mechanisms and
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Animals; Arginine; Aspartic Acid; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cysteine; Genetic Vectors; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Peptide Fragments; Peptide T; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden

2020
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
    Nature communications, 2021, 03-29, Volume: 12, Issue:1

    Topics: Alternative Splicing; Amino Acid Sequence; Arginine; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Heterogeneous Nuclear Ribonucleoprotein A1; Humans; Male; Methylation; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; RNA, Small Interfering; Spliceosomes; Substrate Specificity

2021
Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells.
    Nature communications, 2021, 04-23, Volume: 12, Issue:1

    Topics: Animals; Arginine; Cell Line, Tumor; Cell Nucleus; DNA-Binding Proteins; Epigenesis, Genetic; Epigenomics; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mitochondria; Muscle Proteins; Oxidative Phosphorylation; Prostatic Neoplasms; Signal Transduction; TEA Domain Transcription Factors; Transcription Factors

2021
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
    Anticancer research, 2017, Volume: 37, Issue:7

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Arginine; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Tartrate-Resistant Acid Phosphatase

2017
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Angiogenesis, 2018, Volume: 21, Issue:1

    Topics: Amidohydrolases; Animals; Arginine; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; PC-3 Cells; Platelet Endothelial Cell Adhesion Molecule-1; Prostatic Neoplasms; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A

2018
Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
    The journal of gene medicine, 2018, Volume: 20, Issue:10-11

    Topics: Alleles; Amino Acid Substitution; Arginine; Case-Control Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Iran; Male; Meta-Analysis as Topic; Odds Ratio; Polymorphism, Single Nucleotide; Prognosis; Prostatic Neoplasms; Risk Factors; X-ray Repair Cross Complementing Protein 1

2018
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    ACS combinatorial science, 2019, 04-08, Volume: 21, Issue:4

    Topics: Amidohydrolases; Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokines; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Nude; Molecular Docking Simulation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Prostatic Neoplasms; Pyridines; Signal Transduction; Transcription Factors; Vascular Endothelial Growth Factor A

2019
piRNA-DQ722010 contributes to prostate hyperplasia of the male offspring mice after the maternal exposed to microcystin-leucine arginine.
    The Prostate, 2019, Volume: 79, Issue:7

    Topics: Animals; Arginine; Argonaute Proteins; Bacterial Toxins; Cell Line, Tumor; Cyanobacteria Toxins; Disease Models, Animal; Drinking Water; Epithelial Cells; Female; Fresh Water; Hyperplasia; Leucine; Male; Marine Toxins; Maternal Exposure; Mice; Mice, Inbred BALB C; Microarray Analysis; Microcystins; Phosphatidylinositol 3-Kinases; Pregnancy; Prostate; Prostatic Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Water Pollution

2019
Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-30, Volume: 111, Issue:39

    Topics: Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Autophagy; Cell Death; Cell Line, Tumor; Chromatin; DNA, Neoplasm; Humans; Hydrolases; Male; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Mitochondria; Nuclear Envelope; Polyethylene Glycols; Prostatic Neoplasms; Reactive Oxygen Species

2014
Arginine deprivation and autophagic cell death in cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-30, Volume: 111, Issue:39

    Topics: Arginine; Cell Death; DNA, Neoplasm; Humans; Male; Prostatic Neoplasms

2014
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.
    Journal of immunology (Baltimore, Md. : 1950), 2015, Dec-01, Volume: 195, Issue:11

    Topics: Amino Acid Transport Systems, Basic; Animals; Arginase; Arginine; Biological Transport; Cationic Amino Acid Transporter 2; Cell Line, Tumor; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Cells; Nitric Oxide Synthase Type II; Prostatic Neoplasms; Reactive Oxygen Species; T-Lymphocytes

2015
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Sep-22, Volume: 106, Issue:38

    Topics: Amino Acid Sequence; Animals; Arginine; Binding Sites; Binding, Competitive; Cell Line, Tumor; Chromatography, Affinity; Endocytosis; Humans; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; Neuropilin-1; Peptide Fragments; Peptide Library; Peptides; Prostatic Neoplasms; Protein Binding; Tissue Distribution; Transfection; Transplantation, Heterologous; Vascular Endothelial Growth Factor A

2009
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
    The Prostate, 2010, Dec-01, Volume: 70, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Black or African American; DNA Primers; Ethnicity; Humans; Male; Middle Aged; Models, Genetic; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Proline; Prostatic Neoplasms; Risk Factors; Tumor Suppressor Protein p53

2010
Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.
    Pflugers Archiv : European journal of physiology, 2011, Volume: 461, Issue:1

    Topics: Arginine; Calcium; Cell Line; Cell Line, Tumor; Cell Membrane; Clotrimazole; Cold Temperature; Endoplasmic Reticulum; Glycine; Humans; Male; Menthol; Prostate; Prostatic Neoplasms; Pyrazines; Pyridines; Pyrimidinones; TRPM Cation Channels

2011
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Mar-01, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Animals; Arginine; CD11b Antigen; Cell Proliferation; Disease Progression; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelopoiesis; NG-Nitroarginine Methyl Ester; Piperazines; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones; T-Lymphocytes; Tumor Cells, Cultured

2011
GPRC6A regulates prostate cancer progression.
    The Prostate, 2012, Volume: 72, Issue:4

    Topics: Adenocarcinoma; Animals; Arginine; Calcium; Cell Line, Tumor; Cell Proliferation; Chemotaxis; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Disease Progression; Humans; In Vitro Techniques; Male; Mice; Mice, Knockout; Osteocalcin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, G-Protein-Coupled; RNA, Messenger; RNA, Small Interfering

2012
Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
    The Prostate, 2012, Volume: 72, Issue:4

    Topics: Adenocarcinoma; Apoptosis; Arginine; Carboxypeptidases; Cell Line, Tumor; Cell Survival; Humans; Male; Nitric Oxide; Prolactin; Prostatic Neoplasms; RNA, Small Interfering; Signal Transduction; Testosterone; Up-Regulation

2012
Deprivation of arginine by recombinant human arginase in prostate cancer cells.
    Journal of hematology & oncology, 2012, Apr-30, Volume: 5

    Topics: Apoptosis; Arginase; Arginine; Blotting, Western; Cell Survival; Humans; Male; Ornithine Carbamoyltransferase; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2012
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
    Nature genetics, 2002, Volume: 32, Issue:4

    Topics: Aged; Amino Acid Substitution; Arginine; Case-Control Studies; DNA Mutational Analysis; Endoribonucleases; Gene Deletion; Gene Dosage; Genetic Predisposition to Disease; Germ-Line Mutation; Heterozygote; Homozygote; Humans; Male; Middle Aged; Pedigree; Point Mutation; Prostate-Specific Antigen; Prostatic Neoplasms

2002
Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids.
    International journal of cancer, 2003, Apr-10, Volume: 104, Issue:3

    Topics: Antioxidants; Apoptosis; Arginine; Benzoates; Buthionine Sulfoximine; Caspase 3; Caspases; Enzyme Inhibitors; Epidermal Growth Factor; Fluorescein; Free Radical Scavengers; Humans; Hydrogen Peroxide; Imidazoles; Immunoenzyme Techniques; Indicators and Reagents; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured; Vitamin E

2003
During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry.
    Biochemistry, 2003, Apr-01, Volume: 42, Issue:12

    Topics: Amino Acid Sequence; Animals; Apoptosis; Arginine; Base Sequence; Binding Sites; DNA, Complementary; HL-60 Cells; HMGA1a Protein; Humans; Male; Mass Spectrometry; Methylation; Molecular Sequence Data; Peptide Mapping; Prostatic Neoplasms; Rats; Recombinant Proteins; Sequence Homology, Amino Acid; Tumor Cells, Cultured

2003
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 1

    Topics: Alleles; Arginine; Case-Control Studies; Cell Movement; Collagen; Disease Progression; DNA; DNA, Complementary; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Genotype; Glycine; Homozygote; Humans; Immunohistochemistry; Laminin; Male; Neoplasm Metastasis; Polymorphism, Genetic; Prostatic Neoplasms; Proteoglycans; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Cell Surface; Receptors, Fibroblast Growth Factor; Receptors, Urokinase Plasminogen Activator; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Up-Regulation; Wound Healing

2004
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
    Cancer research, 2005, Jan-15, Volume: 65, Issue:2

    Topics: Animals; Arginine; Carcinoma, Squamous Cell; Echocardiography; Endothelium, Vascular; Fluorescein; Humans; Leucine; Male; Mice; Mice, Inbred C3H; Mice, Nude; Microbubbles; Myocardium; Neoplasm Transplantation; Neovascularization, Pathologic; NIH 3T3 Cells; Oligopeptides; Prostatic Neoplasms; Transplantation, Heterologous

2005
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
    The Journal of experimental medicine, 2005, Apr-18, Volume: 201, Issue:8

    Topics: Adenocarcinoma; Animals; Arginase; Arginine; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Interferon-gamma; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase; Organ Culture Techniques; Prostatic Neoplasms; T-Lymphocyte Subsets; Tyrosine

2005
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
    European urology, 2005, Volume: 48, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Alanine; Alleles; Arginine; Biomarkers, Tumor; Case-Control Studies; Dihydrotestosterone; Disease Progression; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Leucine; Luteinizing Hormone; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Risk Factors; Sex Hormone-Binding Globulin; Sweden; Terminal Repeat Sequences; Testosterone; Threonine; Valine

2005
Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.
    The Journal of biological chemistry, 2005, Oct-14, Volume: 280, Issue:41

    Topics: Alanine; Arginine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Separation; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Genes, Tumor Suppressor; Glutathione; Glutathione Transferase; HeLa Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Immunoprecipitation; Male; Microscopy, Fluorescence; Neoplasm Metastasis; Oxidative Stress; Plasmids; Point Mutation; Prostatic Neoplasms; Protein Binding; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Transfection; Two-Hybrid System Techniques

2005
Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors.
    The Journal of biological chemistry, 2006, Mar-31, Volume: 281, Issue:13

    Topics: Acyltransferases; Animals; Arginine; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Estrogen Receptor alpha; Genes, Reporter; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Luciferases; Male; Methylation; Nuclear Receptor Coactivator 2; p300-CBP Transcription Factors; Prostatic Neoplasms; Protein Methyltransferases; Protein-Arginine N-Methyltransferases; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Repressor Proteins; RNA, Small Interfering; Trans-Activators; Transcriptional Activation

2006
Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation.
    Journal of proteome research, 2006, Volume: 5, Issue:5

    Topics: Arginine; Carbon Isotopes; Fourier Analysis; Humans; Isotope Labeling; Male; Mass Spectrometry; Neoplasm Metastasis; Prostatic Neoplasms; Proteins; Reproducibility of Results; Software; Tumor Cells, Cultured

2006
Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant.
    Carcinogenesis, 2007, Volume: 28, Issue:6

    Topics: Aged; Amino Acid Substitution; Arginine; Case-Control Studies; Dietary Fats, Unsaturated; Endoribonucleases; Glutamine; Humans; Male; Prostatic Neoplasms; Risk Factors; Trans Fatty Acids

2007
Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Research communications in molecular pathology and pharmacology, 2004, Volume: 115-116

    Topics: Antioxidants; Arginine; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Formazans; Humans; Laminin; Lysine; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Proline; Prostatic Neoplasms; Proteoglycans; Tetrazolium Salts

2004
Expression of arginase II in prostate cancer.
    International journal of oncology, 2008, Volume: 32, Issue:2

    Topics: Androgens; Arginase; Arginine; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasms, Hormone-Dependent; Ornithine-Oxo-Acid Transaminase; Polyamines; Prostatic Neoplasms; Receptors, Androgen

2008
Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers.
    Cancer research, 1997, Oct-15, Volume: 57, Issue:20

    Topics: Adult; Amino Acid Substitution; Arginine; Base Sequence; Chromosome Mapping; Chromosomes, Human, Pair 8; Cystine; DNA, Neoplasm; Exons; Homeodomain Proteins; Humans; Male; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prostate; Prostatectomy; Prostatic Neoplasms; Sequence Deletion; Transcription Factors

1997
Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
    The Prostate, 1998, Jan-01, Volume: 34, Issue:1

    Topics: alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha-2-Antiplasmin; Amino Acid Sequence; Animals; Antithrombin III; Arginine; Biomarkers, Tumor; Cell Line; Chromogenic Compounds; Cricetinae; Humans; Kallikreins; Male; Molecular Sequence Data; Oligopeptides; Peptides; Prostatic Neoplasms; Recombinant Fusion Proteins; Serine Proteinase Inhibitors; Serpins; Substrate Specificity; Tissue Kallikreins

1998
Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells.
    Molecules and cells, 2000, Jun-30, Volume: 10, Issue:3

    Topics: Amino Acid Sequence; Animals; Apoptosis; Arginine; Astrocytes; Cell Line; Culture Media, Conditioned; Cycloheximide; Cytoprotection; DNA Fragmentation; G1 Phase; Humans; Hydrolases; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; Molecular Sequence Data; Nitric Oxide; Paclitaxel; Prostatic Neoplasms; Protein Synthesis Inhibitors; Rats; Sequence Alignment; Sertoli Cells; Tumor Cells, Cultured

2000
Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
    Carcinogenesis, 2001, Volume: 22, Issue:6

    Topics: Arginine; bcl-2-Associated X Protein; Binding Sites; Breast Neoplasms; Codon; Consensus Sequence; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; Female; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Substrate Specificity; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2001
[Advanced cancer of the prostate: chemotherapy].
    Bulletin du cancer, 1986, Volume: 73, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Fluorouracil; Humans; Male; Prostatic Neoplasms; Teniposide

1986